Straight from the Desk
Syz the moment
Live feeds, charts, breaking stories, all day long.
- All
- equities
- United States
- Macroeconomics
- Food for Thoughts
- markets
- Central banks
- Fixed Income
- bitcoin
- Asia
- europe
- investing
- geopolitics
- gold
- technical analysis
- Commodities
- AI
- Crypto
- Technology
- nvidia
- ETF
- earnings
- Forex
- china
- Real Estate
- oil
- banking
- energy
- Volatility
- magnificent-7
- apple
- Alternatives
- emerging-markets
- switzerland
- tesla
- United Kingdom
- Middle East
- amazon
- assetmanagement
- microsoft
- russia
- ethereum
- ESG
- meta
- Industrial-production
- bankruptcy
- Healthcare
- Turkey
- Global Markets Outlook
- africa
- Market Outlook
- brics
- performance
The breadth in commodity price spikes is the highest in two years
Source: Bloomberg
The higher a stock's price goes, the more expensive it gets. Right? Well, not always.
A year ago, when NVDA was selling at $277, its earnings per share was $0.82 and its P/E ratio was 147x Today, NVDA's share price is up +284% to $1,064.... BUT... Its earnings per share is up +629% to $5.98. Its P/E has fallen to 62x... forward P/E is now at 30x So, NVDA is CHEAPER today than it was a year ago. Source: Adam Khoo Trader, Piranha Profits
Did you know that the S&P 500 has been basically flat vs gold over the last six years? 🤔
Source: Markets & Mayhem, BofA
A key point on Nvidia story: $NVDA CEO Jensen Huang doesn't lack demand. What he lacks is supply.
In an exclusive interview following last week's earnings Huang said demand for its programs will soon outstrip supply, with the complexity of these chips also challenging the company's efforts to keep pace. Source: Yahoo Finance
New weight-loss drug ETF
“Roundhill Investments' GLP-1 & Weight Loss ETF (OZEM), which began trading last week, pairs leaders Eli Lilly and Novo Nordisk with players developing new treatments for weight loss and diabetes. CEO Dave Mazza said his firm is capitalizing on explosive growth potential in the industry…Eli Lilly and Novo Nordisk each hold a roughly 20% weighting in the ETF. The three next largest positions are Zealand Pharma, Amgen and Chugai Pharmaceutical, each of which have a weighting under 5%”. Source: CNBC, Bloomberg
BREAKING: RFK JR. SHAKES UP PRESIDENTIAL RACE
Robert F. Kennedy Jr. has accepted the Libertarian Party's presidential nomination, introducing a dynamic twist to the upcoming election that could disrupt the prospects for both Trump and Biden. This move puts RFK on the ballot in enough states to theoretically secure the 270 Electoral College votes necessary for a presidential victory. Kennedy's decision was announced during a contentious moment at the Libertarian Party convention, where he was nominated unexpectedly. Trump and Biden's campaigns are reportedly uneasy about Kennedy's candidacy, fearing it could siphon crucial votes in a tight race. Kennedy has positioned his campaign as a fusion of third-party and independent voters to challenge the traditional two-party system. Source: Daily Mail thru Mario Nawfal
One of the most famous Jim Cramer meme
Source: Not Jerome Powell on X
Investing with intelligence
Our latest research, commentary and market outlooks

